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. Association of Transcription Factor APRF 
< and Protein Kinase Jak 1 with the IL-6 
Signal Transducer gp 130 
ate-earlyaenet (12-14). The bindinc spec-
ifidty of APRF is shared by the interfaut .., 
(IFN-'Y)-.ctivation factor (GAF) (14), 
which .. Identical to the ISGF-la p91 
protein (8, 10). Because APRF croD-IaCII 
with an antiserum raised apinst the ISGF-
3a p91 NH1-terminus, it is likdy ID be 
related to p91 (J3). Thus. the ........ 
pathway tX tu; may be similar ID _ 
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Because activation of ISGF-la by IfN.cI 
involves tyrOSine phosphorylation of the 
pIU, p91, and pM components and GM 
activation by IFN-'Y requires the lyIOIine 
phosphorylation of p91 (9, 10), wc ima-
tigated whether APRF becomes tyroIiDe 
.phosphorylated in response to IL-6. I.ysara 
from untreated or IL-6-tteated human ~ 
atoma (HepG2) ceDs were aubjecud 10 
immunopredpitation with an IllUiser-. to 
the NH1-terminus of p91 and pM (md-
p91,p84) and analy%ed .by an immtlDlDYot 
wtthmonoclonal antibodies to plw.ispboq.. 
rosine. The IL-6 induced the appearance. 
. Friedemann Horn· . 
Interleukln-8. leukemla inhibitory facIDr, oncostatin M. Interleukln-11, and cilialy neur0-
trophic factor bind ~ recaptor complexes that share the signal transducer gp130. Upon 
binding. the ligands rapidly activate DNA binding of acute·phase response factor (APRF). 
a protein antigenicalyrelaled to the p91 subun/t of the interferon-stimulated gene factor~ 
(JSGF-3a). These c:ytokines caused 1JroSine phosphorylation of APRF and ISGF-3a p91. 
Protein klnases oflheJak familywereal;so rapidly tyrosine phosphorylated, and boIh APRF 
and Jak1 associated with gp130. These data indicate that Jak family protein k1nases may 
participate in Il-6 signaJing and thalAPRF may be activated in a complex with gp130. 
Interleukin-6 (11.-6). leukemia inhibitory 
.factor (UF), oncoaatin M (OSM), and 
ciliary . neurotrophic factor (CNn) are 
members of a family of cytolcines and neu-
ronal differentiation factors (I) or neu- ' 
rolcines (2). These f.tctors exen pleioaopic 
effects on multiple cell types and bind to 
composite receptOlS cOntaining the signal 
nansducer gp130 (3). The neurolcine Keep-
tors belong to a mperfamily of cyIIikine 
receptors sharing bod\ structural and imc-
tional features (4). Cytokine receptolS ini-
tiate related signaling pathways chaclcter-
ized by association with and activation of 
protein tyrosine ldnases of the JaIc family 
(5, 6) and the reauitment of latent cyto-
plasmic transcription factors of the ISGF-
3a family by tyrosine phosphorylation and 
subsequent ngdear ttanslocation (7-10). 
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The IL-6 signal transduction pathway 
has not yet been elucidated, but the in-
volvement of Jalc family members has been 
proposed (ll). A latent cytoplasmic tran-
scription factor, APRF, is rapidly actiwted 
in response to IL-6, UF, OSM. nAl, and 
CNTF (12. 13). Alter activation, the 89-
kD protein binds to IL-6 response elements 
identified in the promoter regions of various 







two major tyrosine-phospborylated prouin 
bands of 91 and 89 ID (Fig. W. The 
91-kD band was also observed aCta- JFN..y 
treatment tXHepG2 cells (Fig. lA) and .. 
immunopredpitated by other antisea 10 
p91, demonstrating its identity with ISGF-
3a p91 (lS). Tyrosine-phosphorylatecl p91 
has a higher apparent molecular abe IIfiu 
SDS-polyacrylamide gel elec:tlupluesis 
(pAGE) than unphosphorylated p91 (10). 
In fact, when immunoblotted with 8DDse-
C Anl-PTtJa) - ~ ~ .!!. 
Pr --+-.-. 
66~:::":::===:=I 
Fig. 1. Tyrosine phosphory1ation of APRF and ISGF-3a p91 in response to IL~ (A) HepG2 eels (10') 
were treated for 20 min without or wiIh tunan IL~ (100 unitll/ml) or IFN-y (251l9'm1). eels were 
rinsed with cold phosphate-buffered sa&le and lysed in O.5-ml1ysis bulfer (24) for 20 oWl at O'C. 
Proteins in the Iysates were irnrTlJnopnlCipilated with anti-p91.p84 (4 pJ) (25). Irrm.ne couple .. 
were separated by SOs.PAGE (7% geI), transferred to poIyvinyIdifluoride membrane (Qiabrane, 
Diagen). and probed with monocIonaI anlibocIies to phospholyrosine (PY20. ICN). To wrify 
application of equal protein anoc.rts. we sIripped and rEiprobed the blot with antisenm to p91 (25). 
The unphosphorylated and phosphorylated forms of p91 (lower and I..W8f band. r~ are 
incfacated by arrowheads (26). 19G. im'an)g1obul'1fl G. Molecular size markers are indicated on fie . 
left in kiIodaltoos. (8) Phosphoamino acid analysis of APAF. The 32p..Jabeled HepG2 eels were 
stimulated with IL~ or IFN-y as atJo.te. The APRF and p91 were irnmunoprecipiated with 
anti-p91.p84, protein irnn'ulobIoUed. and visualized by autoradiography (Jower panel). the 
phosphorylated APRF band (brackeCs) was excised and subjected to phosphoamino acid analysis . 
(27) (upper paneI). The positions 01 utileled phosphoamino acid standards are indieaIed S, · 
serine; T, threonine; and Y. tyrosine. (C) Inhibition of bincflllg of APRF to DNA by arllilodies to 
phosphotyrosine. Nuclear extracts were prepared from HepG2 cells l1eaIed for 15 min wiII\ I.~ 
(100 units/m!) as described (12) and were incubated 0Iiemight at O"C with allbldes to 
phosphotyrosine (anti-PT) in the absence or presence of phosphotyrome (1 mM). The DNA bindng 
of APRF was examined in a gel reta'daIion assay (28). 
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IIIDl to p91. the IL-6- a~d IFN-l-induced 
~ce of • retarded p91 band was 
observed (Fig. lA). Activation of p91 
DNA binding by fL.6 was also demonstrat-
ed by eel retardation assays (I S). 
The 89-kD phosphoprotein band in-
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fig. 2. Tyrosre phosphorylation of Jak family 
protein kinases in response to IL-6 and other 
cytokines, CA) Tme course of Jakl phosphoryl- . 
ation in response to IL-6, Lysates from HepG2 
<:ells treated wih L-6 (200 units/(T11) for various 
periods (IabeIed in minutes) were imn'ulopre-
cipiIaled with a1tiserum to Jakl (6) or preim-
fTUl8 senm (pee) and irnnulobIotted with an-. 
tibodies to phosp/"lotyI:osine (upper paneI). The 
position of Jakl (130 kO) is indicated. We 
verified equal protein load by reprobing with 
antiserum 10 Jakl (lower panel). (8) TIfTl8 
eotne of Ty1<2 phosphorylation in response to 
!L-6. anaIyzed as described above for Jakl 
(29). The posiioo of Tyk2 (134 kO) is il'l!icated. 
(C) Induction d Jakl . APRF. and ISGF-3a p91 
tyrosine phosphoIytalion by different cytokines. 
The HepG2 eels were slirrulated for 10 min 
wiIhout or will tunan IL-6 (200 units/ml). OSM 
(20 ngImI). or FN-y (25 1'9'mI). and FNJ cells 
(30) were treated for 10 min with tunan UF (25 
1l!)tnI). rat CNTF (20 nglmI). or tunan IL-ll (SO 
1'9'mI). CeI tjsaIes were immunoprecipitated 
with antiserun 10 Jakl or anli-p91.p84 and 
irmulc>bIoned with antibodies to phospholy-
rosine (31). 
After immunopm:ipitadon from 1L-6-
treated. lZp_labeIed Hep02 celIs, phospho-
serine and phospbotyrosine but no phoa-
phothreonine weft detected in an APRF 
prote!A hydrolysat£ (Fig. 18). The presence 
01 phosphcxyrosine in the DNA-binding 
form of APRF .. con6nned by the obser-
vation that incuI:.don with antiphosphoty-
rosine antibodies spedfically interfered with 
the formation oI1he APRF-DNA complex 
(Fig. IC). These findings show that both 
15GF-3a p91 and APRF are tyrosine phoa-
phoaylated in raponse to IL-6. The time 
course cl this df'ect (IS) Corresponded 
closely CO that deunnined (or the induction 
01 APRF DNA-llinding activity (12), indi-
cating that latmt APRF is activated by 
tyrosine phosphorylation. 
Tyrosine pro«dn kinase activity copre-
cipitates with gp130 from IL-6-treated celIs (In. Antisera co the Jak family members 
T y1c2 and Jalcl ftre used to test whether 
: _' <§ fegp130 
" : . 
' ,i! . 
: . "feJak1 116 • It . 
IrmUlO- ~ AnlhJak1 
blot: phosjA.."osme 
fig. 3. AssociaIian of Jakl with the IL-6 signal 
transducer gpl30. Untreated HepG2 eels 
(right panel) or eels treated for 5 min with L-6 
(200 UliIsImI) (leA panel) were washed wiIh 
icEH:oId phosphaIe buffered saline and cdIect-
eel. CeIs were aoss-linked (32) and lysed. and 
proteins were imuloprecipitated with preirn-
mune senm (pe) 01 anbbod"l8S to gp130 or 
Jak1 as in<icated. The croSs-&nker was then 
cleaved upon boiling in sat11'Ie buffer. and 
proteins were anaIyzed by imrTulobIotting wiIh 
antiboOes to pho6photyrosine or Jak1, as n. 
caled. 
these kinases respaad to JL.6 stimulation cl · 
HepG2· celIs. Boda Jald. and, to a lesser -
extent. Tykl 1fta tranJiendy . tyrOSine 
phosphorylated Ia.IapONe to IL-6 (Fie. 2. 
A and 8). Also. UF. OSM, CNTF. and 
1I,11atfmulated _ tyrotine phosphoryla-
tion cl Jul. as .. as cl APRF and p91 
(Fig. 2C). Thus. ~tion of these 
proteins appean ID be eenerally induced 
upon activation of 11'130. The maeiUtude 
of the response to clif'erent C}'to1cinea var- , 
led. but the reIadw extents of APRF and-
Jul phosphorylman changed coordinate-
ly. Furthermore. die time course of L6-
induced Jul and T jk2 tyrosine phospho-
rylation matched wdl with the one • 
served for APRF (IS). Therefore, JaIc &In-
ily members mar be involved in the 
tyrosine phospbcqbdon and activation cl 
APRF. . . 
The tyrosine pfophorylation eX Jalcl 
was also induced IIy IFN..., (Fig. 2C). In 
contrast to '1L:-6. which only transiendy 
activates APRF 8Dd p91. IFN-l induces 
p91 DNA bindincactivity for several hours 
in HepG2 cells ('4). Similarly, IFN-l In-
duced the tyro5iDe phosphorylation of both 
p91 and JAKl '- at least 1 hour (15). 
confirming a dole correlation between ty-
rosine phosphoryLdon of members of the 
.Jak and ISGFJa 6milies. 
To examine 1IIaethcr JaIc family mem-
~ may be 8aldared with gpl30, we 
studied the possI6, of coprecipitations of 
Jul and 11>130- When lysates from IL-6-
treated HepG2 cds were immunoprecipi-
bated with antiII:nm co Jakl. coprecipita-
don of ~ted gp130 was 
observed (Fig. 3) (l8). ~y, JaJct 
was copredpltaraf upon bnmunoprecipita-
don of gpl30. Sciawlation by IL-6 was not 
required for dUI dect (Fig. 3). indicating 
that Ju1 ~ interacts either di-
RCtly or indiru:dr with JP 130 and hence 11 
B 
1 2 3 • 
FIg • . 4. ~ of gpl30 
with APRF from L-6-stimJlaled 
hepatoma eels. (A) HepG2 or 
FAO cells were Rated for 10 min 
with tunan IL-6 (200 units/ml). 
OSM (20 ngImI). or UF (25 ngImI). 
CeD Iysates prepared in the pres-
ence or abSence of dithiottveitol . 
(On) were irmuloprecipitated 
with ~ antibodies to le ~"~"-f'=:::::;:~:::! 
gpl30 01 with ri-p91.p84. as ~QD __ I",.. 
indicaled, and were irnmJnobIot-
ted with antibodies 10 phosphoty-
rosit*t. The open arrowhead indicates the position of the c:opre4!1nd 19O-1d) protein after LF 
treatment. Lane M shows molecular size markers (IabeIed on 111ft in kiIodaItons) •. (8) The 
coprecipitated 1~ phosphoprotein readS with antixIdies to s;p130. HepG2 cells treated for 10 
tnin wiIh IL-6 (200 ooils/ml) were lysed and Iubjected 10 imuqJIec~ with antisen.m to 
gpl30 (lane 1) or with anli-p91.p84 in the absence of OTT (lane 2). lbe ri-p91.p84 imrTulopre-
cipitates from 2 x 107 cells were washed wiIh lysis bulfer: wi1hcU OTT (lane 3) 01 with 1 mM OTT 
(lane 4). The supemalants of both wash stepa were .lbjecIed to a seccncI ~ecipilation with 
antbodies to gp130 (33). All in'mJnoprecipites were then analysed by irTlrrunobIotting wiIh 
antbodies 10 phosphotyrosine. . 
SCIENCE • VOL ••• • ....... 1994 
.. 
• 
. AME: JOB # ' PAGE::3 SESS: 4 0l1TPUT: Tue Dec 706:56:391993 
./305/team lIscience/originaIIl38a 115618 
li1cely to represent at least part cl me 
tyrOSine kinase activity copreclpitaUd 1ridl 
gpl30. 
HomodimeriJadon « gp130 and .aiva-
don of its assoc:iated potein kinase .aivity 
have only been obIcIwd in the .t.Dce of 
reducing agentI (In. Thus, disul6de bidea 
appear to be impottamt in the ",,,.WM' of 
an active receptOr complex. When ..... ~ 
, pedpitadon c:J bepaaoma~ll lysMa wiIh 
anti·p91,p84 was per:bmed under DCIlI'e-
duc:ing c:onditions, a pbosphoprocciD IimiIar 
in me (145 kO) to gpllO was copre+ \icarul 
from ~ted Hq(:;Z cells ~ 4A). 
The 14S-m protein could be releaRd fiom 
the immune complexa by dit:hiodrre:ird and • 
then immunoptecipiJlel by antibxliies ID 
gp13O, proving its ideotity with gpllO (Fie. 
4B). Several antisera ID p91 that do DOt 
recognize APRF fa&d to c:opecipitate 
gp130 (15). Theseuperiments do DOt show 
whether the association of APRF ...111'130 
is dirCct· or mediated by other ",cbeL 
However, because c:opecipitatioo of 1P13O 
is observed only in the absence of ~. 
thrcitol. an active gp130 homodUaer seemS 
to be required fOr its interaction wiIh APRF. 
Therefore, association c:J APRF 1riIh 1P13O 
is lilcely to be ligand-ioIuced and .., dim::t 
the factor into a complex with gplJO..asso. 
dated tyrosine kinases. Similarly. alig3nd. 
induced association of p91 with, the epider-
mal growth factOr lUlIep(or has reccs:td, been 
reported (19). Aft« tRattnent olra hepa-
toma (FAO) cells with UF, gpoo and a 
190-kO protein wee coprecipiaraf wiIh 
·anti-p91.p84 (Fig. 4A). This prcniD, pr0b-
ably represents the UF receptor, wLich bet-
erodimerizes with gpl 30 upon UF ('eaI mmt 
(20). Although OSM has been prDpO"ed ID ' 
bind to a gpl30-LIF receptor hamdimcr 
(21), only gpl30 was coprecipiallaf fiom 
OSM-treated HepG2 cells (Fig. 41\). 
These data indicate that the RcJWing 
cascade induced by 11,-6 and reWal Dcmn 
is similar to that initiated by ~ cytO-
kincs and is characterized by actinbon and 
tyrosine phosphorylation of ISGF-la-mat· 
cd transcription factors and of Jak family 
protein kinases. The observation that me 
ttu)SCription factor APRF associates with 
the iP130 signal transducer upOn IL-6 aam-
ulation suggests that a aan.scriptiOll &ctor 
can be regulated by Its physical intencdon 
with a plasma membrane receptor. 
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